v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Bausch Health Companies Inc. Shareholders’ Deficit
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non- controlling Interest
Beginning Balance (in shares) at Dec. 31, 2024     367,800,000        
Beginning Balance at Dec. 31, 2024 $ (322) $ (1,279) $ 10,490 $ 234 $ (9,824) $ (2,179) $ 957
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     1,900,000        
Common shares issued under share-based compensation plans 0   $ 20 (20)      
Share-based compensation 89 89   89      
Employee withholding taxes related to share-based awards (19) (19)   (19)      
Vesting of B+L equity compensation 0 (34)   (34)     34
Noncontrolling interest distributions (9)           (9)
Net income (loss) 42 90     90   (48)
Other comprehensive (loss) income 366 389       389 (23)
Ending Balance (in shares) at Jun. 30, 2025     369,700,000        
Ending Balance at Jun. 30, 2025 147 (764) $ 10,510 250 (9,734) (1,790) 911
Beginning Balance (in shares) at Mar. 31, 2025     369,500,000        
Beginning Balance at Mar. 31, 2025 (240) (1,183) $ 10,508 220 (9,882) (2,029) 943
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     200,000        
Common shares issued under share-based compensation plans 0   $ 2 (2)      
Share-based compensation 46 46   46      
Employee withholding taxes related to share-based awards (3) (3)   (3)      
Vesting of B+L equity compensation 0 (11)   (11)     11
Noncontrolling interest distributions (9)           (9)
Net income (loss) 128 148     148   (20)
Other comprehensive (loss) income 225 239       239 (14)
Ending Balance (in shares) at Jun. 30, 2025     369,700,000        
Ending Balance at Jun. 30, 2025 $ 147 (764) $ 10,510 250 (9,734) (1,790) 911
Beginning Balance (in shares) at Dec. 31, 2025 370,531,987   370,500,000        
Beginning Balance at Dec. 31, 2025 $ 377 (554) $ 10,516 357 (9,667) (1,760) 931
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     3,400,000        
Common shares issued under share-based compensation plans 0   $ 28 (28)      
Share-based compensation 106 106   106      
Employee withholding taxes related to share-based awards (42) (42)   (42)      
Vesting of B+L equity compensation 0 (49)   (49)     49
Noncontrolling interest distributions (10)           (10)
Cash settlement of share-based awards (2) (2)   (2)      
Net income (loss) (1,171) (1,165)     (1,165)   (6)
Other comprehensive (loss) income $ (60) (65)       (65) 5
Ending Balance (in shares) at Jun. 30, 2026 373,901,440   373,900,000        
Ending Balance at Jun. 30, 2026 $ (802) (1,771) $ 10,544 342 (10,832) (1,825) 969
Beginning Balance (in shares) at Mar. 31, 2026     373,500,000        
Beginning Balance at Mar. 31, 2026 (1,082) (2,059) $ 10,542 295 (11,090) (1,806) 977
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     400,000        
Common shares issued under share-based compensation plans 0   $ 2 (2)      
Share-based compensation 54 54   54      
Employee withholding taxes related to share-based awards (8) (8)   (8)      
Vesting of B+L equity compensation 0 3   3     (3)
Noncontrolling interest distributions (10)           (10)
Net income (loss) 260 258     258   2
Other comprehensive (loss) income $ (16) (19)       (19) 3
Ending Balance (in shares) at Jun. 30, 2026 373,901,440   373,900,000        
Ending Balance at Jun. 30, 2026 $ (802) $ (1,771) $ 10,544 $ 342 $ (10,832) $ (1,825) $ 969